1. Simionescu, N., M. Nemecz, Anca-Roxana Petrovici, I.S. Nechifor, Razvan-Cristian Buga and M.G. Dabija et al., 2022. Microvesicles and microvesicle-associated micrornas reflect glioblastoma regression: Microvesicle-associated mir-625-5p has biomarker potential. Int. J. Mol. Sci. Vol. 23. 10.3390/ijms23158398.
   CrossRef  |  Direct Link  |  
2. Filippi, A., A. Constantin, N. Alexandru, C.A. Mocanu and M.L.Vlad, 2022. Vla4-enhanced allogeneic endothelial progenitor cell-based therapy preserves the aortic valve function in a mouse model of dyslipidemia and diabetes. Pharmaceutics. Vol. 14. 10.3390/pharmaceutics14051077.
   CrossRef  |  Direct Link  |  
3. Constantin, A., I.K. Comarița, N. Alexandru, A. Filippi and F. Bojin et al., 2022. Stem cell‐derived extracellular vesicles reduce the expression of molecules involved in cardiac hypertrophy—In a model of human-induced pluripotent stem cell-derived cardiomyocytes. Front. Pharmacol., 10.3389/fphar.2022.1003684.
   CrossRef  |  Direct Link  |  
4. Comariţa, I.K., A. VÙlcu, A. Constantin, A. Procopciuc and F. Safciuc et al., 2022. Therapeutic potential of stem cell-derived extracellular vesicles on atherosclerosis-induced vascular dysfunction and its key molecular players. Front. Cell Dev. Biol. Vol. 10. 10.3389/fcell.2022.817180.
   CrossRef  |  Direct Link  |  
5. Simionescu, N., R. Zonda, A.R. Petrovici and A.a Georgescu, 2021. The multifaceted role of extracellular vesicles in glioblastoma: Microrna nanocarriers for disease progression and gene therapy. Pharmaceutics. Vol. 13. 10.3390/pharmaceutics13070988.
   CrossRef  |  Direct Link  |  
6. Georgescu, A. and M. Simionescu, 2021. Extracellular vesicles: Versatile nanomediators, potential biomarkers and therapeutic agents in atherosclerosis and COVID-19-related thrombosis. Int. J. Mol. Sci. Vol. 22. 10.3390/ijms22115967.
   CrossRef  |  Direct Link  |  
7. Alexandru, N., A. Procopciuc, A. VÙlcu, I.K. Comariţa, E. Bӑdilӑ and A. Georgescu, 2021. Extracellular vesicles—incorporated microRNA signature as biomarker and diagnosis of prediabetes state and its complications. Rev. Endocr. Metab. Disord., 23: 309-332.
   CrossRef  |  Direct Link  |  
8. Filippi, A., A. Constantin, N. Alexandru, G. Voicu and C.A. Constantinescu et al., 2020. Integrins u03b14u03b21 and u03b1vu03b23 are reduced in endothelial progenitor cells from diabetic dyslipidemic mice and may represent new targets for therapy in aortic valve disease. Cell Transplant., 10.1177/0963689720946277.
   CrossRef  |  Direct Link  |  
9. Constantin, A., A. Filippi, N. Alexandru, M. Nemecz and A. Georgescu, 2020. Extracellular vesicles from adipose tissue stem cells in diabetes and associated cardiovascular disease; pathobiological impact and therapeutic potential. Int. J. Mol. Sci., 10.3390/ijms21249598.
   CrossRef  |  Direct Link  |  
10. Alexandru, N., E. Andrei, F. Safciuc, E. Dragan, A.M. Balahura, E. Badila and A. Georgescu, 2020. Intravenous administration of allogenic cell-derived microvesicles of healthy origins defends against atherosclerotic cardiovascular disease development by a direct action on endothelial progenitor cells. Cells, 10.3390/cells9020423.
    CrossRef  |  Direct Link  |  
11. Tucureanu, M.M., A. Filippi, N. Alexandru, C.A. Constantinescu and L. Ciortan et al., 2019. Diabetes-induced early molecular and functional changes in aortic heart valves in a murine model of atherosclerosis. Diabetes Vasc. Dis. Res., 10.1177/1479164119874469.
    CrossRef  |  Direct Link  |  
12. Gherghiceanu, M., N. Alexandru, S.L. Magda, A. Constantin and M. Nemeczet al., 2019. Extracellular Vesicles As Valuable Players In Diabetic Cardiovascular Diseases. In: Extracellular Vesicles, De Bona, A.G. (Ed.)., IntechOpen Rijeka, Croatia, ISBN: 978-1-78923-944-7, pp: 1-25.
13. Constantin, A., M. Dumitrescu, M. Nemecz, A. Picu and B. Smeu et al., 2019. Sera of obese type 2 diabetic patients undergoing metabolic surgery instead of conventional treatment exert beneficial effects on beta cell survival and function: Results of a randomized clinical study. Obesity Surg., 29: 1485-1497.
    CrossRef  |  Direct Link  |  
14. Ceafalan, L.C., O.C. Ioghen, D.S. Marta, A. Constantin and N. Alexandru et al., 2019. Extracellular Vesicles as Risk Factor in Neurodegenerative Diseases. In: Extracellular Vesicles, De Bona, A.G. (Ed.)., InTechOpen, Rijeka, Croatia, ISBN: 978-1-78923-944-7, pp: 1-21.
15. Alexandru, N., F. Safciuc, A. Constantin, M. Nemecz and G. Tanko et al., 2019. Platelets of healthy origins promote functional improvement of atherosclerotic endothelial progenitor cells. Front. Pharmacol., Vol. 10. 10.3389/fphar.2019.00424.
    CrossRef  |  Direct Link  |  
16. Alexandru, N., A. Constantin, M. Nemecz, I.K. Comariu0163a and A. Vu00eelcu et al., 2019. Hypertension associated with hyperlipidemia induced different microrna expression profiles in plasma, platelets, and platelet-derived microvesicles; effects of endothelial progenitor cell therapy. Front. Med., 10.3389/fmed.2019.00280.
    CrossRef  |  Direct Link  |  
17. Alexandru, N., A. Constantin, M. Nemecz, I.K. Comariu0163a and A. Vu00eelcu et al., 2019. Hypertension associated with hyperlipidemia induced different MicroRNA expression profiles in plasma, platelets, and platelet-derived microvesicles; effects of endothelial progenitor cell therapy. Front. Med., 10.3389/fmed.2019.00280.
    CrossRef  |  Direct Link  |  
18. Stępien, E.L., M. Durak-Kozica, A. Kaminska, M. Targosz-Korecka and M. Libera et al., 2018. Circulating ectosomes: Determination of angiogenic microRNAs in type 2 diabetes. Theranostics, 8: 3874-3890.
    CrossRef  |  Direct Link  |  
19. Nemecz, M., A. Constantin, M. Dumitrescu, N. Alexandru, A. Filippi, G. Tanko and A. Georgescu, 2018. The distinct effects of palmitic and oleic acid on pancreatic beta cell function: The elucidation of associated mechanisms and effector molecules. Front. Pharmacol., Vol. 9. 10.3389/fphar.2018.01554.
    CrossRef  |  Direct Link  |  
20. Georgescu, A., 2018. Understanding the functional role of micro RNA‐214‐3p in atherosclerosis for the identification of novel targeted therapies to prevent or reverse endothelial cell dysfunction and stimulate autophagy. ACTA Physiol., Vol. 222. 10.1111/apha.12997.
    CrossRef  |  Direct Link  |  
21. Costa, A., N. Alexandru, F. Silva, A. MagalhÂes, S. Dias and A. Georgescu, 2018. Extracellular vesicles by in situ hybridization using formalin-frozen paraffin embedded sections. Ann. Romanian Soci. Biol., 21: 29-35.
    CrossRef  |  Direct Link  |  
22. Alexandru, N., E. Andrei, L. Niculescu, E. Dragan, V. Ristoiu and A. Georgescu, 2017. Microparticles of healthy origins improve endothelial progenitor cell dysfunction via microRNA transfer in an atherosclerotic hamster model. Acta Physiol. 10.1111/apha.12896.
    CrossRef  |  
23. Alexandru, N., A. Costa, A. Constantin, D. Cochior and A. Georgescu, 2017. Microparticles: From biogenesis to biomarkers and diagnostic tools in cardiovascular disease. Curr. Stem Cell Res. Therapy, 12: 89-102.
    Direct Link  |  
24. Nemecz, M., N. Alexandru, G. Tanko and A. Georgescu, 2016. Role of microRNA in endothelial dysfunction and hypertension. Curr. Hypertens. Rep., 18: 1-21.
25. Georgescu, A., N. Alexandru, E. Andrei, E. Dragan, D. Cochior and S. Dias, 2016. Effects of transplanted circulating endothelial progenitor cells and platelet microparticles in atherosclerosis development. Biol. Cell, 108: 219-243.
    CrossRef  |  
26. Alexandru, N., E. Badila, E. Weiss, D. Cochior, E. Stępień and A. Georgescu, 2016. Vascular complications in diabetes: Microparticles and microparticle associated MicroRNAs as active players. Biochem. Biophys. Res. Commun., 472: 1-10.
    CrossRef  |  
27. Georgescu, A., 2014. Cardiovascular Dysfunction: New Biomarkers and Therapies. Scholars' Press, Saarbrucken, Germany, ISBN-13: 978-3-639-71643-6, Pages: 180.
28. Badila, E., A.M. Daraban, S. Ghiorghe, A. Georgescu, N. Alexandru, D. Bartos and C. Tirziu, 2014. Rethinking cardiovascular therapy-the effect of irbesartan on circulating microparticles and endothelial progenitor cells in patients with hypertension and dyslipidemia. Farmacia, 62: 93-106.
    Direct Link  |  
29. Andrei, E., N. Alexandru, E. Dragan and A. Georgescu, 2014. Flow cytometric analysis of circulating microparticles and endothelial progenitor cells in plasma; a research tool for atherosclerosis and therapy. Exp. Clin. Cardiol., 20: 1554-1563.
    Direct Link  |  
30. Alexandru, N., E. Badila and A. Georgescu, 2014. The role of endothelial progenitor cells in the cardiovascular disease pathogenesis. J. Stem Cells Res. Rev. Rep., Vol. 1, No. 2. .
    Direct Link  |  
31. Ton, B.H.T., Q. Chen, G. Gaina, C. Tucureanu and A. Georgescu et al., 2013. Activation profile of dorsal root ganglia Iba-1 (+) macrophages varies with the type of lesion in rats. Acta Histochemica, 115: 840-850.
    CrossRef  |  PubMed  |  Direct Link  |  
32. Georgescu, A., N. Alexandru, M. Nemecz, I. Titorencu and D. Popov, 2013. Irbesartan administration therapeutically influences circulating endothelial progenitor cell and microparticle mobilization by involvement of pro-inflammatory cytokines. Eur. J. Pharmacol., 711: 27-35.
    CrossRef  |  PubMed  |  Direct Link  |  
33. Alexandru, N., D. Popov, E. Dragan, E. Andrei and A. Georgescu, 2013. Circulating endothelial progenitor cell and platelet microparticle impact on platelet activation in hypertension associated with hypercholesterolemia. PloS One, Vol. 8. 10.1371/journal.pone.0052058.
    CrossRef  |  PubMed  |  Direct Link  |  
34. Alexandru, N. and A. Georgescu, 2013. Circulating microparticles and microRNAs as players in atherosclerosis. World J. Hematol., 2: 16-19.
    CrossRef  |  Direct Link  |  
35. Titorencu, I., M.G. Albu, F. Anton, A. Georgescu and V.V. Jinga, 2012. Collagen-dexamethasone and collagen-D₃ scaffolds for bone tissue engineering. Mol. Cryst. Liquid Cryst., 555: 208-217.
    CrossRef  |  Direct Link  |  
36. Stancu, C.S., A. Georgescu, L. Toma, G.M. Sanda and A.V. Sima, 2012. Glycated low density lipoproteins alter vascular reactivity in hyperlipidemic hyperglycemic hamsters. Ann. Roman. Soc. Cell Biol., 17: 9-15.
    Direct Link  |  
37. Georgescu, A., N. Alexandru, E. Andrei, I. Titorencu and E. Dragan et al., 2012. Circulating microparticles and endothelial progenitor cells in atherosclerosis: pharmacological effects of irbesartan. J. Thromb. Haemost., 10: 680-691.
    CrossRef  |  PubMed  |  Direct Link  |  
38. Alexandru, N., D. Popov and A. Georgescu, 2012. Platelet dysfunction in vascular pathologies and how can it be treated. Thromb. Res., 129: 116-126.
    CrossRef  |  PubMed  |  Direct Link  |  
39. Lupu, M., M. Khalil, E. Andrei, F. Iordache and K. Pfannkuche et al., 2011. Integration properties of Wharton's jelly-derived novel mesenchymal stem cells into ventricular slices of murine hearts. Cell. Physiol. Biochem., 28: 63-76.
    CrossRef  |  PubMed  |  Direct Link  |  
40. Georgescu, A., N. Alexandru, M. Nemecz, I. Titorencu and D. Popov, 2011. Enoxaparin reduces adrenergic contraction of resistance arterioles in aging and in aging associated with diabetes via engagement of MAP kinase pathway. Blood Coagul. Fibrinol., 22: 310-316.
    CrossRef  |  PubMed  |  Direct Link  |  
41. Georgescu, A., N. Alexandru, A. Constantinescu, I. Titorencu and D. Popov, 2011. The promise of EPC-based therapies on vascular dysfunction in diabetes. Eur. J. Pharmacol., 669: 1-6.
    CrossRef  |  PubMed  |  Direct Link  |  
42. Georgescu, A., N. Alexandru and D. Popov, 2011. Ongoing Data on Vascular Endothelial Cell Dysfunction: An Update. In: From Vascular Cell Biology to Cardiovascular Medicine, Georgescu, A. and F. Antohe (Eds.). Kerala, India, ISBN: 978-81-7895-503-2, pp: 125-141.
43. Georgescu, A., D. Popov, A. Constantin, M. Nemecz, N. Alexandru, D. Cochior and A. Tudor, 2011. Dysfunction of human subcutaneous fat arterioles in obesity alone or obesity associated with Type 2 diabetes. Clin. Sci., 120: 463-472.
    CrossRef  |  PubMed  |  Direct Link  |  
44. Georgescu, A., 2011. Vascular dysfunction in diabetes: The endothelial progenitor cells as new therapeutic strategy. World J. Diabetes, 2: 92-97.
    CrossRef  |  PubMed  |  Direct Link  |  
45. Georgescu, A. and F. Antohe, 2011. Editor of the International Monograph from Vascular Cell Biology to Cardiovascular Medicine. In: Research Signpost Transworld Research Network, De Gortari, P. (Ed.). Kerala, India.
46. Alexandru, N., D. Popov, E. Dragan, E. Andrei and A. Georgescu, 2011. Platelet activation in hypertension associated with hypercholesterolemia: Effects of irbesartan. J. Thromb. Haemost., 9: 173-184.
    CrossRef  |  PubMed  |  Direct Link  |  
47. Alexandru, N., A. Georgescu, M. Amuzescu, C. Zamfir, A. Badila and D. Popov, 2011. Platelet reactivity in chronic venous insufficiency. Clin. Lab., 57: 527-534.
    PubMed  |  
48. Nemecz, M., D. Popov and A. Georgescu, 2010. Phosphorylation/dephosphorylation signaling events in the aorta of streptozotocin-injected Golden Syrian Hamsters. Ann. RSCB, 25: 28-34.
49. Chahed, S., A.S. Leroyer, M. Benzerroug, D. Gaucher and A. Georgescu et al., 2010. Increased vitreous shedding of microparticles in proliferative diabetic retinopathy stimulates endothelial proliferation. Diabetes, 59: 694-701.
    CrossRef  |  PubMed  |  Direct Link  |  
50. Alexandru, N., D. Popov and A. Georgescu, 2010. Intraplatelet oxidative/nitrative stress: Inductors, consequences and control. Trends Cardiovasc. Med., 20: 232-238.
    CrossRef  |  PubMed  |  Direct Link  |  
51. Popov, D., M. Nemecz, M. Dumitrescu, A. Georgescu and F.D. Bohmer, 2009. Long-term high glucose concentration influences Akt, ERK1/2 and PTP1B protein expression in human aortic smooth muscle cells. Biochem. Biophys. Res. Commun., 388: 51-55.
    CrossRef  |  PubMed  |  Direct Link  |  
52. Georgescu, A., N. Alexandru, D. Popov, M. Amuzescu and E. Andrei et al., 2009. Chronic venous insufficiency is associated with elevated level of circulating microparticles. J. Thromb. Haemost., 7: 1566-1575.
    CrossRef  |  PubMed  |  Direct Link  |  
53. Georgescu, A., F. Pluteanu, M.L. Flonta, E. Badila, M. Dorobantu and D. Popov, 2007. Nebivolol induces a hyperpolarizing effect on smooth muscle cells in the mouse renal artery by activation of beta-2-adrenoceptors. Pharmacology, 81: 110-117.
    CrossRef  |  PubMed  |  Direct Link  |  
54. Georgescu, A., D. Popov, N. Alexandru, A. Tudor and M. Simionescu, 2007. Structural and functional assessment of small arteries in obesity and type II diabetes. Proceedings of the 76th Congress of the European Atherosclerosis Society , Volume 8, June 10-13, 2007, Helsinki, Finland, pp: 229-229.
55. Georgescu, A., D. Popov, E. Dragan, E. Dragomir and E. Badila, 2007. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension. Eur. J. Pharmacol., 570: 149-158.
    CrossRef  |  PubMed  |  Direct Link  |  
56. Schneider, M., A. Georgescu, C. Bidmon, M. Tutsch, E.H. Fleischmann, D. Popov and M. Pischetsrieder, 2006. Detection of DNA-bound advanced glycation end‐products by immunoaffinity chromatography coupled to HPLC-diode array detection. Mol. Nutr. Food Res., 50: 424-429.
    CrossRef  |  PubMed  |  Direct Link  |  
57. Georgescu, A., N. Alexandru, E. Constantinescu and D. Popov, 2006. Effect of gap junction uncoupler heptanol on resistance arteries reactivity in experimental models of diabetes, hyperlipemia and hyperlipemia-diabetes. Vasc. Pharmacol., 44: 513-518.
    CrossRef  |  PubMed  |  Direct Link  |  
58. Georgescu, A., F. Safciuc and E. Constantinescu, 2006. The effect of aging on the vasomotor function of rat basilar artery. Proc. Roman. Acad. Ser. B., 1: 13-17.
59. Georgescu, A., D. Popov, E. Dragomir, E. Dragan and M. Simionescu, 2006. Nebivolol protects and reverses endothelial dysfunction in diabetes associated with hypertension: Molecular mechanisms involved. Proceedings of the 24th Conference of the European Society for Microcirculation, August 30-September 2, 2006, Amsterdam, Netherlands, pp: 81-81.
60. Georgescu, A., F. Pluteanu, M.L. Flonta, E. Badila, M. Dorobantu and D. Popov, 2005. The cellular mechanisms involved in the vasodilator effect of nebivolol on the renal artery. Eur. J. Pharmacol., 508: 159-166.
    CrossRef  |  PubMed  |  Direct Link  |  
61. Voinea, M., A. Georgescu, A. Manea, E. Dragomir, I. Manduteanu, D. Popov and M. Simionescu, 2004. Superoxide dismutase entrapped-liposomes restore the impaired endothelium-dependent relaxation of resistance arteries in experimental diabetes. Eur. J. Pharmacol., 484: 111-118.
    CrossRef  |  PubMed  |  Direct Link  |  
62. Radu, D.L., A. Georgescu, C. Stavaru, A. Carale and D. Popov, 2004. Double transgenic mice with type 1 diabetes mellitus develop somatic, metabolic and vascular disorders. J. Cell. Mol. Med., 8: 349-358.
    CrossRef  |  PubMed  |  Direct Link  |  
63. Georgescu, A., D. Popov, M. Capraru and M. Simionescu, 2003. Enoxaparin: A low molecular weight heparin, restores the altered vascular reactivity of resistance arteries in aged and aged-diabetic hamsters. Vasc. Pharmacol., 40: 167-174.
    CrossRef  |  PubMed  |  Direct Link  |  
64. Georgescu, A. and D. Popov, 2003. The contractile response of the mesenteric resistance arteries to prostaglandin F_2α; effects of simultaneous hyperlipemia-diabetes. Fundam. Clin. Pharmacol., 17: 683-689.
    CrossRef  |  PubMed  |  Direct Link  |  
65. Radu, L., C. Stavaru, A. Georgescu, D. Popov and C. Coman, 2002. Transgenic mouse model of type 1 diabetes. Proc. Jpn. Soc. Immunol., 32: 11-16.
66. Popov, D., G. Costache, A. Georgescu and M. Enache, 2002. Beneficial effects of L-arginine supplementation in experimental hyperlipemia-hyperglycemia in the hamster. Cell Tissue Res., 308: 109-120.
    CrossRef  |  PubMed  |  Direct Link  |  
67. Popov, D., G. Costache and A. Georgescu, 2001. Altered Vascular Reactivity of the Resistance Arteries: Lessons from the Hyperlipemic-Hyperglycemic Hamster Model. In: New Insights into Experimental Diabetes, Cheta, D.M. (Ed.). The Publishing House of the Romanian Academy, Rome, ISBN: 9789732708712, pp: 211-222.
68. Georgescu, A., D. Popov and M. Simionescu, 2001. Mechanisms of impeded brady kinininduced vasodilation in experimental hyperlipemia-hyperglycemia: Contribution of nitric oxide and Ca2+ activated K+ channels. Fundam. Clin. Pharmacol., 15: 335-342.
69. Georgescu, A., D. Popov and L. Vladimirescu, 2001. Effect of blocking the intercellular communication junctions on the contractile response of the resistance arteries. Curr. Problems Tech. Cell. Mol. Biol., 6: 85-90.
70. Georgescu, A. and D. Popov, 2001. Vascular reactivity of the resistance arteries to potassium in combined hyperlipemia-hyperglycemia. Proc. Roman. Acad. Ser. B., 1: 111-117.
71. Popov, D., G. Costache, A. Georgescu, M. Enache and M. Simionescu, 2000. Mechanisms of the impeded relaxation of the resistance arteries in hyperlipemia-hyperglycemia. Proceedings of the 5th Annual Meeting of the European Council for Blood Pressure and Cardiovascular Research, October 13-15, 2000, Noordwijkerhout, Netherlands -.
72. Georgescu, A. and D. Popov, 2000. Age-dependent accumulation of advanced glycation endproducts is accelerated in combined hyperlipidemia and hyperglycemia, a process attenuated by L-arginine. J. Am. Aging Assoc., 23: 33-40.
    CrossRef  |  PubMed  |  Direct Link  |  
73. Costache, G., D. Popov, A. Georgescu, M. Cenuse, V.V. Jinga and M. Simionescu, 2000. The effects of simultaneous hyperlipemia-hyperglycemia on the resistance arteries, myocardium and kidney glomeruli. J. Submicroscop. Cytol. Pathol., 32: 47-58.
    PubMed  |  
74. Costahe, G., D. Popov, A. Georgescu and M. Simionescu, 1999. Functional-structural alterations of the resistance arteries in experimental hyperlipemia or hypergliycemia. Proc. Roman. Acad. Ser. B., 1: 33-37.
75. Popov, D., G. Costache, A. Georgescu, M. Cenuse and M. Simionescu, 1998. In hyperlipemichyperglycemic hamsters the micro and macroangiopathic alterations are accompanied by modifications that may lead to an increased blood pressure. Proceedings of the 3rd European Research Conference on Blood Pressure and Cardiovascular Disease, October 16-18, 1998, Netherlands -.
76. Georgescu, A., G. Costache, D. Popov and M. Simionescu, 1998. The abnormal responses to PGF2 and potassium of the mesenteric resistance arteries in hyperlipemic- hyperglycemic hamsters. Proceedings of the 3rd European Research Conference on Blood Pressure and Cardiovascular Disease, October 16-18, 1998, Netherlands -.
77. Georgescu, A., D. Popov and G. Costache, 1998. Vascular reactivity of resistance arteries of hyperlipemic-hyperglycemic hamsters in the presence of vasoconstrictor agents. Curr. Problems Tech. Cell. Mol. Biol., 3: 124-129.
78. Georgescu, A. and D. Popov, 1998. Influence of experimental diabetes on the cells of vascular wall. Studii si Cercetari de Biochimie, 41: 107-117.
79. Costache, G., A. Georgescu, M. Cenuse, D. Popov and M. Simionescu, 1998. Alterations of resistance vessels and capillaries in hyperlipemic-hyperglycemic hamsters. Proceedings of the 70th EAS Congress, September 6-9, 1998, Geneva -.
80. Georgescu, A., D. Popov and M. Hasu, 1997. Quantitative fluorimetric analysis of advanced glycosylation end products in mesenteric arteries and lens crystallin of hyperlipemic and simultaneously hyperlipemic and hyperglycemic hamsters. Curr. Problems Tech. Cell. Mol. Biol., 2: 65-68.
81. Costache, G., M. Hasu, D. Popov and A. Georgescu, 1997. The use of the myograph technique for the investigation of the vascular reactivity: A review. Curr. Problems Tech. Cell. Mol. Biol., 2: 38-43.